AstraZeneca Scores FDA Win For Imfinzi In Perioperative Stomach Cancer

 
• By Alaric DeArment
  
Picture of AstraZeneca Logo on building
AstraZeneca won approval for Imfinzi in perioperative treatment of gastric and gastroesophageal cancers. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip